Nanobiotix (NBTX) Assets (2018 - 2025)

Nanobiotix (NBTX) has 8 years of Assets data on file, last reported at $78.9 million in Q4 2025.

• In Q4 2025, Assets rose 9.49% year-over-year to $78.9 million; the TTM figure through Dec 2025 stood at $312.9 million (down 10.71% YoY), while the FY2025 annual figure was $76.6 million, up 4.92% from the prior year.
• Assets climbed to $78.9 million in Q4 2025, from $72.0 million in the prior quarter.
• Across five years, Assets topped out at $116.4 million in Q4 2021 and bottomed at $61.0 million in Q4 2022.
• A 5-year average of $85.9 million and a median of $78.9 million in 2025 frame the typical range for Assets.
• Annual changes were most pronounced in 2022 — Assets plunged 47.62% — and 2023, when it jumped 65.67%.
• Year by year, Assets stood at $116.4 million in 2021, then plunged by 47.62% to $61.0 million in 2022, then jumped by 65.67% to $101.0 million in 2023, then fell by 28.69% to $72.0 million in 2024, then increased by 9.49% to $78.9 million in 2025.
• The last three Assets figures came in at $78.9 million (Q4 2025), $72.0 million (Q4 2024), and $101.0 million (Q4 2023), per Business Quant data.

Peer Comparison